NCT06963632View on ClinicalTrials.gov

A Real-world Study on Golidocitinib-based Therapeutic Regimens for the Treatment of Patients With Peripheral T-cell Lymphoma

Not yet recruitingOBSERVATIONAL

Enrollment

1,000

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2027

Conditions

Peripheral T-cell Lymphoma (PTCL)

All Listed Sponsors

lead

Ruijin Hospital

OTHER